Joseph W Windsor
Overview
Explore the profile of Joseph W Windsor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chhibba T, Gros B, King J, Windsor J, Gorospe J, Leibovitzh H, et al.
J Crohns Colitis
. 2025 Mar;
PMID: 40065502
The pathogenesis of inflammatory bowel disease (IBD) involves a complex interplay between genetic, environmental, and microbial factors. Many of these environmental determinants are modifiable, offering opportunities to prevent disease or...
2.
Coward S, Benchimol E, Bernstein C, Avina-Zubieta A, Bitton A, Carroll M, et al.
Am J Gastroenterol
. 2024 Feb;
119(8):1563-1570.
PMID: 38299598
Introduction: Canada has a high burden of inflammatory bowel disease (IBD). Historical trends of IBD incidence and prevalence were analyzed to forecast the Canadian burden over the next decade. Methods:...
3.
Shaffer S, Kuenzig M, Windsor J, Bitton A, Jones J, Lee K, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S45-S54.
PMID: 37674503
Approximately one out of every 88 seniors has inflammatory bowel disease (IBD), and this is expected to increase in the future. They are more likely to have left-sided disease in...
4.
Murthy S, Kuenzig M, Windsor J, Matthews P, Tandon P, Benchimol E, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S83-S96.
PMID: 37674502
Cancer is a major cause of morbidity and mortality among people with inflammatory bowel disease (IBD). Intestinal cancers may arise as a complication of IBD itself, while extra-intestinal cancers may...
5.
Murthy S, Weizman A, Kuenzig M, Windsor J, Kaplan G, Benchimol E, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S97-S110.
PMID: 37674501
The therapeutic landscape for inflammatory bowel disease (IBD) has changed considerably over the past two decades, owing to the development and widespread penetration of targeted therapies, including biologics and small...
6.
Windsor J, Kuenzig M, Murthy S, Bitton A, Bernstein C, Jones J, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S1-S8.
PMID: 37674500
The burden of inflammatory bowel disease (IBD) (i.e., associated direct and indirect costs, prevalence of disease, personal impact to the individual and to caregivers) continues to increase in Canada. The...
7.
Graff L, Geist R, Kuenzig M, Benchimol E, Kaplan G, Windsor J, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S64-S75.
PMID: 37674499
Psychiatric disorders are 1.5 to 2 times more prevalent in persons with inflammatory bowel disease (IBD) than in the general population, with pooled prevalence estimates of 21% for clinical anxiety...
8.
Targownik L, Bollegala N, Huang V, Windsor J, Kuenzig M, Benchimol E, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S55-S63.
PMID: 37674498
Sex (the physical and physiologic effects resulting from having specific combinations of sex chromosomes) and gender (sex-associated behaviours, expectations, identities, and roles) significantly affect the course of inflammatory bowel disease...
9.
El-Matary W, Carroll M, Deslandres C, Griffiths A, Kuenzig M, Mack D, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S35-S44.
PMID: 37674497
Rates of inflammatory bowel disease (IBD) in Canadian children and adolescents are among the highest in the world, and the incidence is rising most rapidly in children under five years...
10.
Mathias H, Rohatinsky N, Murthy S, Novak K, Kuenzig M, Nguyen G, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S111-S121.
PMID: 37674496
Rising compounding prevalence of inflammatory bowel disease (IBD) (Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18:56-66.) and...